Browsing Category
Pharma Industry News
4729 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Catalight study challenges ABA dosage norms: Real-world data shows more therapy hours don’t predict better adaptive outcomes
Catalight’s new study challenges ABA dosage guidelines by showing that more therapy hours do not predict better adaptive outcomes. Read what this means.
MetaVia (NASDAQ: MTVA) raises $9.3m to advance DA-1726 after positive Phase 1b obesity data
MetaVia raised $9.3M to fund DA-1726 after strong obesity trial results. Find out how this dual-agonist strategy could reshape the GLP-1 landscape.
Emmecell names ex-AbbVie executive Ramin Valian as CEO to lead cell therapy platform
Emmecell names Ramin Valian as CEO to guide its magnetic cell delivery platform toward pivotal trials. Find out what this leadership shift means for the industry.
Positive interim ADAPT trial data place Creative Medical Technology Holdings at a critical clinical crossroads in regenerative pain care
Find out how positive interim ADAPT trial data could place Creative Medical Technology Holdings at a critical inflection point in non-opioid regenerative pain treatment.
Cultivate highlights Standard Process’ strategy to shape the business of longevity-focused clinical education
Discover how Cultivate positions Standard Process to shape the fast-growing business of longevity-focused practitioner education and healthy aging care.
Independent cardiac safety review finds no cardiotoxicity for Moleculin’s annamycin, removing a major anthracycline overhang
Independent reviewers found no cardiotoxicity for Moleculin’s annamycin in 90 subjects. See how this milestone de-risks the oncology pipeline.
Salesforce adds Viz.ai hospital triggers to Agentforce platform in pharma engagement push
Viz.ai and Salesforce are embedding real-time clinical triggers into Agentforce. Find out how this changes pharma go-to-market strategy in 2025.
Bajaj Healthcare (NSE: BAJAJHCARE) Q3 FY26 earnings: API exports double, PAT up 34%
Bajaj Healthcare’s API exports doubled in Q3 FY26, driving 31% revenue growth. Find out what its CNS pipeline and CDMO ramp mean for future expansion.
Repare Therapeutics (NASDAQ: RPTX) investors back acquisition by nonprofit XenoTherapeutics; court approval pending
Repare shareholders approve Xeno acquisition; cash payout rises to $2.20 after Gilead deal. Find out what this means for biotech investors and rivals.
AVEO Oncology begins Phase 1b/2 ficlatuzumab trial in elderly AML patients via Blood Cancer United collaboration
AVEO Oncology has begun a Beat AML trial for ficlatuzumab in elderly AML patients. See how this could reshape front-line cancer care for high-risk groups.